Inventor
YANG GI HYEOK
KR19 patents
⚠️ This page may combine multiple inventors who share the name “YANG GI HYEOK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDY TOX INC
9 patentsUS10293034B2May 21, 2019
Pharmaceutical liquid composition of botulinum toxin with improved stability and method of use
MEDY TOX INC13 citations91
US10143728B2Dec 4, 2018
Long lasting effect of new botulinum toxin formulations
MEDY TOX INC12 citations91
US9220780B2Dec 29, 2015
Pharmaceutical liquid composition of botulinum toxin with improved stability
MEDY TOX INC23 citations91
US9198958B2Dec 1, 2015
Lyophilized preparation of botulinum toxin
MEDY TOX INC16 citations91
US12377137B2Aug 5, 2025
Long lasting effect of new botulinum toxin formulations
MEDY TOX INC0 citations61
US12274739B2Apr 15, 2025
Pharmaceutical liquid composition of botulinum toxin with improved stability
MEDY TOX INC0 citations61
US11957741B2Apr 16, 2024
Long lasting effect of new botulinum toxin formulations
MEDY TOX INC0 citations61
US11596673B2Mar 7, 2023
Long lasting effect of new botulinum toxin formulations
MEDY TOX INC0 citations61
US11590212B2Feb 28, 2023
Long lasting effect of new botulinum toxin formulations
MEDY TOX INC0 citations61
MEDYTOX INC
5 patentsUS10105387B2Oct 23, 2018
Temperature sensitive adhesion prevention composition and use thereof
MEDYTOX INC4 citations68
US11331598B2May 17, 2022
Method of isolating botulinum toxin from botulinum toxin-containing solution
MEDYTOX INC4 citations65
US11517576B2Dec 6, 2022
Methods and compositions of bile acids and salts for reduction of fat
MEDYTOX INC0 citations59
US10729700B2Aug 4, 2020
Methods and compositions of bile acids and salts for reduction of fat
MEDYTOX INC1 citations59
US11198859B2Dec 14, 2021
Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same
MEDYTOX INC0 citations58